Wutah dodolan YoY sajrone 12 wulan kepungkur: Lyell Immunopharma (LYEL)

Logo perusahaan publik Lyell Pharma (LYEL)

The trailing twelve-month sales growth rate demonstrates current revenue dynamics, where the -63.20 mark characterizes this parameter. Lyell Immunopharma (LYEL) is creating an innovative oncology foundation by reprogramming T-cells to combat solid tumors. A lack of debt and a substantial cash reserve guarantee financial stability. However, the narrow specialization of the pipeline creates significant binary risks tied to clinical trial results.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Lyell Immunopharma, Inc. (LYEL): kanggo periode 11.02.2024 - 19.11.2026

Lyell Immunopharma, Inc. (LYEL) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Lyell Immunopharma
Sampel barang lyell.com

Lyell Immunopharma (LYEL) is implementing robotic systems to accelerate the development of T-cell therapies, moving the company into a stage of technological scaling. Analyzing the current sales growth rate over a rolling 12-month period year-over-year, the investor evaluates revenue dynamics through the lens of a TTM calculation, which neutralizes seasonality and reveals the actual trading momentum, determining the fundamental resilience of the business during its transition to commercialization.

Pesaing Lyell Immunopharma (LYEL)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|innate-pharma.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Pyxis Oncology|Compugen Limited (CGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|IO Biotech, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|STRO (sutrobio.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur